Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolised liposomal cyclosporin A versus placebo for bronchiolitis obliterans after allogeneic HSCT
ISRCTN69881892Phase 2Terminated
- Sponsor
- PARI Pharma
- Start
- Mar 2010
- Modality
- Small Molecules, Peptides
01
Overview
Phase 2, randomised trial in Bronchiolitis Obliterans (BO) comparing L-CsA 10 mg once daily plus placebo once daily, L-CsA 10 mg twice daily and Placebo twice daily (3 arms). Started Mar 2010; status: terminated.
02
Drugs
cyclosporine
03
Conditions
Bronchiolitis Obliterans (BO)
Beyond the preview
Go deeper on ISRCTN69881892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN69881892.